Follow
Kate Shearer
Kate Shearer
Verified email at jhu.edu
Title
Cited by
Cited by
Year
Loss to follow‐up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa
K Clouse, A Pettifor, K Shearer, M Maskew, J Bassett, B Larson, ...
Tropical Medicine & International Health 18 (4), 451-460, 2013
1322013
Attrition through multiple stages of pre-treatment and ART HIV care in South Africa
MP Fox, K Shearer, M Maskew, G Meyer-Rath, K Clouse, I Sanne
PLoS One 9 (10), e110252, 2014
692014
Costs of inpatient treatment for multi‐drug‐resistant tuberculosis in S outh A frica
K Schnippel, S Rosen, K Shearer, N Martinson, L Long, I Sanne, ...
Tropical Medicine & International Health 18 (1), 109-116, 2013
662013
Treatment outcomes after 7 years of public-sector HIV treatment
MP Fox, K Shearer, M Maskew, W Macleod, P Majuba, P Macphail, ...
Aids 26 (14), 1823-1828, 2012
602012
Performance of Xpert MTB/RIF, Xpert Ultra, and Abbott RealTime MTB for Diagnosis of Pulmonary Tuberculosis in a High-HIV-Burden Setting
RH Berhanu, A David, P da Silva, K Shearer, I Sanne, W Stevens, L Scott
Journal of clinical microbiology 56 (12), 10.1128/jcm. 00560-18, 2018
532018
Challenges in the evaluation of interventions to improve engagement along the HIV care continuum in the United States: a systematic review
KA Risher, S Kapoor, AM Daramola, G Paz-Bailey, J Skarbinski, K Doyle, ...
AIDS and Behavior 21, 2101-2123, 2017
522017
Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort …
K Schnippel, K Shearer, D Evans, R Berhanu, N Ndjeka
International Journal of Infectious Diseases 39, 89-94, 2015
502015
Marginal structural models to assess delays in second-line HIV treatment initiation in South Africa
JK Rohr, P Ive, CR Horsburgh, R Berhanu, K Shearer, M Maskew, L Long, ...
PloS one 11 (8), e0161469, 2016
462016
Incidence and predictors of herpes zoster among antiretroviral therapy-naive patients initiating HIV treatment in Johannesburg, South Africa
K Shearer, M Maskew, T Ajayi, R Berhanu, P Majuba, I Sanne, MP Fox
International Journal of Infectious Diseases 23, 56-62, 2014
292014
Developing a predictive risk model for first‐line antiretroviral therapy failure in South Africa
JK Rohr, P Ive, CR Horsburgh, R Berhanu, K Shearer, M Maskew, L Long, ...
Journal of the International AIDS Society 19 (1), 20987, 2016
252016
Increases in regimen durability associated with the introduction of tenofovir at a large public‐sector clinic in Johannesburg, South Africa
AT Brennan, M Maskew, P Ive, K Shearer, L Long, I Sanne, MP Fox
Journal of the International AIDS Society 16 (1), 18794, 2013
252013
The right combination–treatment outcomes among HIV-positive patients initiating first-line fixed-dose antiretroviral therapy in a public sector HIV clinic in Johannesburg …
K Hirasen, D Evans, M Maskew, IM Sanne, K Shearer, C Govathson, ...
Clinical epidemiology, 17-29, 2017
232017
Treatment outcomes of over 1000 patients on second‐line, protease inhibitor‐based antiretroviral therapy from four public‐sector HIV treatment facilities across Johannesburg …
K Shearer, D Evans, F Moyo, JK Rohr, R Berhanu, L Van Den Berg, ...
Tropical Medicine & International Health 22 (2), 221-231, 2017
232017
The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa
K Shearer, AT Brennan, M Maskew, L Long, R Berhanu, I Sanne, MP Fox
Journal of the International AIDS Society 17 (1), 19065, 2014
222014
Characterizing breast conditions at an open-access breast clinic in South Africa: a model that is more than cancer care for a resource-limited setting
S Rayne, N Lince-Deroche, C Hendrickson, K Shearer, F Moyo, ...
BMC health services research 17, 1-10, 2017
182017
Impact of choice of NRTI in first‐line antiretroviral therapy: a cohort analysis of stavudine vs. tenofovir
AT Brennan, K Shearer, M Maskew, L Long, I Sanne, MP Fox
Tropical Medicine & International Health 19 (5), 490-498, 2014
132014
Low prevalence of depressive symptoms among stable patients on antiretroviral therapy in Johannesburg, South Africa
K Shearer, D Evans, B Xhosa, K Hirasen, C Bracken, K Mahomed, L Long, ...
Plos one 13 (9), e0203797, 2018
112018
The impact of choice of NNRTI on short-term treatment outcomes among HIV-infected patients prescribed tenofovir and lamivudine in Johannesburg, South Africa
K Shearer, MP Fox, M Maskew, R Berhanu, L Long, I Sanne
PLoS One 8 (8), e71719, 2013
112013
Do bisexual men tell their female partners about having male partners? Results from a national online HIV prevention survey in the United States
K Shearer, C Khosropour, R Stephenson, PS Sullivan
International Journal of Sexual Health 24 (3), 195-204, 2012
112012
Yield of facility-based targeted universal testing for tuberculosis with Xpert and mycobacterial culture in high-risk groups attending primary care facilities in South Africa
RH Berhanu, L Lebina, BAS Nonyane, M Milovanovic, A Kinghorn, ...
Clinical Infectious Diseases 76 (9), 1594-1603, 2023
82023
The system can't perform the operation now. Try again later.
Articles 1–20